Traws Pharma, Inc. Earnings Per Share (Basic)
Traws Pharma, Inc. (TRAW) reported Earnings Per Share (Basic) of -$0.16 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Traws Pharma, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.16.
- Traws Pharma, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.53, a 124.42% decline year-over-year.
- Traws Pharma, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.58.
- Traws Pharma, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.34.
- Traws Pharma, Inc. earnings per share, basic for fiscal 2025 was $0.83.
- Traws Pharma, Inc. earnings per share, basic for fiscal 2024 was -$35.21.
- Traws Pharma, Inc. earnings per share, basic for fiscal 2023 was -$22.57.
- Traws Pharma, Inc. earnings per share, basic for fiscal 2022 was -$0.91.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.16 10-Q · filed 2026-08-14 | -$0.64 10-Q · filed 2026-08-14 | -$1.15 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.50 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2026-03-31 | -$0.53 10-Q · filed 2026-05-15 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.47 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.70 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-12-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$1.13 derived: net income ÷ weighted average shares · filed 2026-08-14 | $0.83 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | -$0.34 10-Q · filed 2025-11-13 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-08-14 | $1.56 10-Q · filed 2025-11-13 | -$1.62 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-06-30 | -$0.11 10-Q · filed 2026-08-14 | $2.02 10-Q · filed 2026-08-14 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.00 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-03-31 | $2.17 10-Q · filed 2026-05-15 | -$1.26 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$2.12 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$9.50 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||||
| 2024-12-31 | -$6.96 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$11.31 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$25.90 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$35.21 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | -$1.49 10-Q · filed 2025-11-13 | -$8.81 10-Q · filed 2024-11-14 | -$22.50 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$31.86 10-Q · filed 2025-11-13 | -$130.87 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | -$20.52 10-Q · filed 2025-08-14 | -$4.87 10-Q · filed 2024-08-15 | -$37.45 10-Q · filed 2025-08-14 | -$5.53 10-Q · filed 2024-08-15 | ||||
| 2024-03-31 | -$5.92 10-Q · filed 2025-05-15 | -$0.24 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | -$22.57 10-K · filed 2025-03-31 | -$0.90 10-K · filed 2024-04-01 | ||||||
| 2023-09-30 | -$5.64 10-Q · filed 2024-11-14 | -$0.23 10-Q · filed 2023-11-14 | -$17.59 10-Q · filed 2024-11-14 | -$0.70 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | -$0.20 10-Q · filed 2024-08-15 | -$0.48 10-Q · filed 2024-08-15 | ||||||
| 2023-03-31 | -$0.28 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | -$0.91 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | -$0.26 10-Q · filed 2023-11-14 | -$0.65 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | -$0.19 10-Q · filed 2023-08-14 | -$0.39 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | -$0.20 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | -$0.96 10-K · filed 2023-03-30 | |||||||
| 2021-09-30 | -$0.22 10-Q · filed 2022-11-14 | -$0.80 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.27 10-Q · filed 2022-08-15 | -$0.59 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | -$0.32 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | -$2.17 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |